Here, we demonstrated in vitro and in vivo the therapeutic potential of IL-15 armored CD70-CAR NK cells to eliminate both CD70+ tumor cells and, most interestingly, also tumor-promoting CD70+ CAFs in CRC and PDAC. The gene discussed is IL15; the disease is colorectal carcinoma.